Morepen Lab hits the roof after Q1 PAT surges over five-fold to Rs 56 cr
Mumbai, Aug. 4 -- The company's consolidated net profit surged 425.05% to Rs 56.39 crore in Q1 FY27 from Rs 10.74 crore in the corresponding quarter last year. Revenue from operations increased 34.07% year-on-year (YoY) to Rs 570.12 crore, marking the company's highest-ever quarterly revenue.
Profit before tax (PBT) jumped 380.46% YoY to Rs 74.52 crore during the quarter.
Operating performance improved sharply, with EBITDA soaring 207% YoY to Rs 87.72 crore. EBITDA margin expanded to 15.25% in Q1 FY27 from 6.65% in the year-ago period, reflecting better operating leverage, an improved product mix and enhanced cost discipline.
Export revenue surged 111% YoY in Q1 FY27.
The company's Active Pharmaceutical Ingredients (API) business regi...
Click here to read full article from source
इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया
हमे संपर्क करें.